The Week Ahead: Fed...
AtriCure Inc. (ATRC: NASDAQ)
$8.80 -0.19 | -2.11%
06/01/12 - 04:00 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 64.40M | 59.01M | 54.53M | 55.26M |
| Cost of Sales | 15.30M | 10.96M | 10.08M | 10.43M |
| Gross Operating Profit | 49.10M | 48.05M | 44.45M | 44.83M |
| Selling, General, and Administrative Expenses | 39.87M | 37.05M | 35.11M | 42.42M |
| Research & Development | 11.86M | 11.53M | 11.41M | 10.61M |
| Operating Income before D & A (EBITDA) | -2.63M | -532.14K | -2.07M | -8.20M |
| Depreciation & Amortization | 2.10M | 2.66M | 2.67M | 2.80M |
| Interest Income | 15.93K | 22.22K | 51.09K | 382.00K |
| Other Income - Net | 104.42K | 258.58K | -4.24M | 756.00K |
| Special Income / Charges | 0.00 | 0.00 | -6.81M | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -4.61M | -2.91M | -15.74M | -9.86M |
| Interest Expense | 814.43K | 861.57K | 812.33K | 364.00K |
| Pre-Tax Income | -5.42M | -3.77M | -16.55M | -10.22M |
| Income Taxes | 30.89K | 19.05K | -58.64K | -57.00K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -5.46M | -3.79M | -16.49M | -10.17M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -5.46M | -3.79M | -16.49M | -10.17M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -5.46M | -3.79M | -16.49M | -10.17M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-5.46M | -3.79M | -9.68M | -10.17M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -5.46M | -3.79M | -16.49M | -10.17M |
| Basic EPS from Continuing Ops. | -0.35 | -0.25 | -1.13 | -0.72 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.35 | -0.25 | -1.13 | -0.72 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.35 | -0.25 | -1.13 | -0.72 |
| Basic Normalized Net Income/Share | -0.35 | -0.25 | -0.66 | -0.72 |
| EPS fr Continuing Ops. | -0.35 | -0.25 | -1.13 | -0.72 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.35 | -0.25 | -1.13 | -0.72 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.35 | -0.25 | -1.13 | -0.72 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.35 | -0.25 | -0.66 | -0.72 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with ATRC
- Portfolio NameUser Type
- ContributorBarrington's Best Stock Pic...
- ContributorBarrington's Updated Best S...
- Userfjknight Portfolio 1
- UserRAPTOR SPRTD RED -0311081629
- Useramarmaharaj Portfolio 1
- UserBarron's Research Reports 5...
- Userralphmalph Portfolio 1
- Useryvebee1
- UserSmall Cap Healthcare
Latest ATRC Headlines from TheStreet
- AtriCure's CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.03.12 | 04:05 pm
- AtriCure's CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.27.12 | 07:02 pm
- Barrington's Best Stock Picks for 2012 01.12.12 | 05:01 am
- AtriCure Update On DEEP AF Feasibility Trial - Call Transcript 12.11.11 | 04:12 pm
- AtriCure's CEO Hosts Update Call On DEEP AF Feasibility Trial - Conference Call Transcript 12.11.11 | 04:12 pm
- AtriCure's CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.01.11 | 05:11 pm
- AtriCure's CEO Discusses Q2 2011 Results - Earnings Call Transcript 08.02.11 | 05:08 pm
- AtriCure CEO Discusses Q1 2011 Results - Earnings Call Transcript 05.04.11 | 03:05 pm
- Barrington Updates Best Stock Picks for 2011 04.12.11 | 06:04 am
- AtriCure, Inc. CEO Discusses Q4 2010 Results - Earnings Call Transcript 02.16.11 | 03:02 pm
Press Releases for ATRC
- AtriCure Reports First Quarter 2012 Financial Results - Business Wire 05.02.12 | 04:05 pm
- AtriCure To Announce First Quarter 2012 Financial Results - Business Wire 04.23.12 | 09:04 am
- AtriCure To Present At 24th Annual Roth Conference - Business Wire 03.06.12 | 08:03 am
- AtriCure Reports Fourth Quarter And Full Year 2011 Financial Results - Business Wire 02.27.12 | 04:02 pm
- AtriCure To Announce Fourth Quarter And Full Year 2011 Financial Results - Business Wire 02.21.12 | 03:02 pm
- AtriCure Announces February Investor Conference Schedule - Business Wire 02.09.12 | 12:02 pm
- AtriCure’s Synergy Ablation System Receives FDA Approval For The Treatment Of Atrial Fibrillation - Business Wire 12.16.11 | 08:12 am
- Update On AtriCure’s DEEP AF Feasibility Trial - Business Wire 11.17.11 | 08:11 am
- AtriCure Announces Upcoming Investor Conference Schedule - Business Wire 11.10.11 | 11:11 am
- AtriCure Reports Third Quarter 2011 Financial Results - Business Wire 11.01.11 | 08:11 am
Partner Headlines for ATRC
- Piper Jaffray Gives Insight to Medical Technology Industry Overview - Benzinga 01.17.12 | 09:01 am
- Will Barrington's Best Stock Picks for 2011 Deliver? - Seeking Alpha 04.18.11 | 07:04 am
- UPDATE 1-AtriCure's heart device gets FDA approval; shares up - Reuters 06.14.10 | 05:06 pm





